Patent · US Active

Liquid preparation comprising pimobendan

US9107952B2 · kind B2 · utility

2Cited by

16References

18Claims

0Family size

Assignee

BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

Martin A. Folger · Ingelheim am Rhein, DE
Stefan Lehner · Wiesbaden, DE

Key dates

Filing date	Nov 5, 2007
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Nov 5, 2028

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB82Y5/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel liquid preparation comprising a substituted benzimidazol, preferably pimobendan as pharmaceutically active compound. In particular, the present invention relates to liquid preparation comprising an etherified cyclodextrin derivative, preferably in a concentration of about 20 to 70% (w/v) and said substituted benzimidazol, preferably in a concentration of about 0.005 to 0.15% (w/w).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.